Stephen A. Block's most recent trade in Niagen Bioscience Inc. was a trade of 20,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Stephen A. Block | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 | - | - | Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Stephen A. Block | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.92 per share. | 15 Mar 2021 | 32,500 | 49,167 (0%) | 0% | 1.9 | 62,400 | Common Stock |
| Niagen Bioscience Inc. | Stephen A. Block | Director | Sale of securities on an exchange or to another person at price $ 11.15 per share. | 15 Mar 2021 | 32,500 | 16,667 (0%) | 0% | 11.2 | 362,375 | Common Stock |
| Niagen Bioscience Inc. | Stephen A. Block | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 32,500 | 0 | - | - | Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Stephen A. Block | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 20,000 | 0 | - | - | Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Stephen A. Block | Director | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 15 Mar 2021 | 20,000 | 16,667 (0%) | 0% | 13.2 | 263,400 | Common Stock |
| Niagen Bioscience Inc. | Stephen A. Block | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.60 per share. | 15 Mar 2021 | 20,000 | 36,667 (0%) | 0% | 2.6 | 52,100 | Common Stock |